Progesterone Receptor B signaling Reduces Breast Cancer Cell Aggressiveness: Role of Cyclin-D1/Cdk4 Mediating Paxillin Phosphorylation

Progesterone-Receptor (PR) positivity is related with an enhanced response to breast cancer therapy, conversely cyclin D1 (CD1) is a retained marker of poor outcome. Herein, we demonstrate that hydroxyprogesterone (OHPg) through progesterone receptor B (PR-B) reduces breast cancer cell aggressivenes...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Autores principales: Montalto, Francesca Ida, Giordano, Francesca, Chiodo, Chiara, Marsico, Stefania, Mauro, Loredana, Sisci, Diego, Aquila, Saveria, Lanzino, Marilena, Panno, Maria Luisa, Andò, Sebastiano, De Amicis, Francesca
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6721542/
https://ncbi.nlm.nih.gov/pubmed/31426542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11081201
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares